Skip to main content
Skip to content
Case File
sd-10-EFTA01394011Dept. of JusticeOther

EFTA Document EFTA01394011

GLDUS137 Forrestal Capital LLC SOF IV — Project Klein Exclusive deal Expected Closing Date: June 2018 Li Fund Secondary NeGP-led Secondary D Single Asset Deal Seller type: Alternative funds Key investment data Transaction summary Invested Capital at close E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare serv

Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01394011
Pages
1
Persons
0
Integrity
Loading PDF viewer...

Summary

GLDUS137 Forrestal Capital LLC SOF IV — Project Klein Exclusive deal Expected Closing Date: June 2018 Li Fund Secondary NeGP-led Secondary D Single Asset Deal Seller type: Alternative funds Key investment data Transaction summary Invested Capital at close E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare serv

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GLDUS137 Forrestal Capital LLC SOF IV — Project Klein Exclusive deal Expected Closing Date: June 2018 Li Fund Secondary NeGP-led Secondary D Single Asset Deal Seller type: Alternative funds Key investment data Transaction summary Invested Capital at close E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare services Use of leverage No Average age at purchase 9 years Description - Motivated quality GP aiming to recapitalize and extend their 2007 mid- market pan-European fund while providing liquidity to LPs - Key value driver is largest independent UK premium distributor in its segment, well positioned to benefit from market tailwinds - Second largest asset is a network of medical and cosmetics UK clinics with a private and affluent customer base - The portfolio also includes an Italian digital marketing company and a management consulting company with blue chip customers - Glendower Capital retains discretion on use of follow-on capital Investment rationale / Glendower Team angle Glendower Team angle - Ability to quickly deliver a bespoke solution leveraging Glendower's track record in complex transactions - Ability to perform extensive diligence, including onsite visits, full access to companies' management and industry specialists - Long 15-year relationship with the GP founder Investment rationale - Four well-invested companies positioned to capture growth opportunities arising from ongoing changes in industry landscape - Key value driver led by industry veteran with a solid track record - Value-add potential from recently implemented cost efficiency initiatives - Opportunity to invest in identified follow-ons at closing, and to contribute additional capital to exploit market dislocations For dear:akin pcaposec rjy. Tha pr reed above I .W s. flOt cliose-d. and these is no guarantee that st., 1 intestine'? wit c:amok:4e or !cart o' Ivbire invested portfc4io or that it Al bei avaliab4e or. aftei fultrRi due diligence. prove suitable for :30F Di This slide should be reed end reviewed in conjunction with the 'Important Infomiation and "Important Perfra mane Information and Notes to Investment Pedormance sections Glendower Capital STRICTLY CONFIDENTIAL CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0099940 CONFIDENTIAL SDNY_GM_00246124 EFTA01394011

Related Documents (6)

Dept. of JusticeOtherUnknown

EFTA Document EFTA01391879

GLDUS142 Ironsides Assel Mgmt SOF IV — Project Klein Exclusive deal Expected Glosing Date: June 2018 El Fund Secondary i Secondary K Single Asset Deal Seller type: Alternative funds Key investment data Transaction summary Invested Capital at dose E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare services Us

1p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01354881

GLDUS125 Gerald Ford SOF IV — Project Klein Exclusive deal Expected Closing Date: June 2018 Li Fund Secondary NeGP-led Secondary D Single Asset Deal Seller type: Alternative funds Key investment data Transaction summary Invested Capital at close E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare services Use

1p
OtherUnknown

NAME SEARCHED: Jeffrey Epstein

DOJ EFTA Data Set 10 document EFTA01296720

114p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01364547

GLOUS238 SOUTHERN FINANCIAL LLC SOF IV — Project Klein Exclusive deal Expected Glosing Date: June 2018 El Fund Secondary i Secondary K Single Asset Deal Seller type: Alternative funds Key investment data Transaction summary Invested Capital at dose E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare services

1p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01382731

S- I/A Table of Contents Perquisite and Personal Benefits Tax Financial Defined Contribution Life Insurance Gross-lip Payments Severance Payments Relocation Benefits Other Compensation Total Name Blanninu(S) Plain(S) (IXS) (2)(S) (3XS) OBS) (5)(S) (5) Frank l. Bisignano 18.812 265 4.902 270,017 — 52,384 186.819 533,199 Michael K. bleborak — — 1.183 — — — — 1.183 Ray E. Winbomc — 984 1.683 2.085,768 - - 2,088.435 Cynthia A. Armine-Klein — 673

1p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01354450

GLDUSI 43 Henry Nicholas SOF IV — Project Klein Exclusive deal Expected Glosing Date: June 2018 El Fund Secondary i Secondary K Single Asset Deal Seller type: Alternative funds Key investment data Transaction summary Invested Capital at dose E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare services Use of

1p

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.